✦ LIBER ✦

Gene delivery to the vasculature mediated by low-titre adeno-associated virus serotypes 1 and 5

✍ Scribed by S. Sen; S. Conroy; S. O. Hynes; J. McMahon; A. O'Doherty; J. S. Bartlett; Y. Akhtar; T. Adegbola; C. E. Connolly; S. Sultan; F. Barry; Z. S. Katusic; T. O'Brien

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 690 KB
Volume: 10
Category: Article
ISSN: 1099-498X
DOI: 10.1002/jgm.1133

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

Vascular gene therapy requires safe and efficient gene transfer in vivo. Recombinant adeno‐associated virus (AAV) is a promising viral vector but its use in the vasculature has produced conflicting results and serotypes other than AAV2 have not been intensively studied. We investigated the efficiency of alternative AAV serotypes for vascular gene delivery in vitro and in vivo.

Methods

Vascular cell lines were transduced in vitro with AAV vectors. Rabbit carotid arteries were transduced with AAV1, 2 and 5 encoding enhanced green fluorescent protein (eGFP) (∼1.4 × 10^9^ DNAse‐resistant particles (drp)). Gene transfer in vivo was assessed at 14 and 28 days. High‐titre doses of AAV2 encoding β‐galactosidase in vivo were also studied.

Results

In vitro, transgene expression was not observed in endothelial cells using AAV2 whereas the use of serotypes 1 and 5 resulted in detectable levels of transgene expression. Coronary artery smooth muscle cells (CASMCs) transduced with AAV2 demonstrated higher levels of GFP expression than AAV1 or 5. Transgene expression in vivo was noted using low‐titre AAV1 and AAV5 (∼1.4 × 10^9^ drp) in the media and adventitia. Only delivery of AAV1eGFP resulted in neointimal formation (3/7 vessels examined), with transgene expression noted in the neointima. Transgene expression with AAV2 was not detected in any layer of the blood vessel wall using low titre (∼10^9^ drp). However, high‐titre (∼10^11^ drp) AAV2 resulted in transduction of cells in the media and adventitia but not the endothelium.

Conclusions

📜 SIMILAR VOLUMES

Adeno-associated virus serotypes 1 to 5

Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency

✍ Ulrich T. Hacker; Lisa Wingenfeld; David M. Kofler; Natascha K. Schuhmann; Sandr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

## Background: Gene therapy is an attractive new approach for the treatment of cancer. therefore, the development of efficient vector systems is of crucial importance in this field. different adeno-associated virus (aav) serotypes have been characterized so far, which show considerable differences

Intra-articular gene delivery and expres

Intra-articular gene delivery and expression of interleukin-1Ra mediated by self-complementary adeno-associated virus

✍ Jesse D. Kay; Elvire Gouze; Thomas J. Oligino; Jean-Noel Gouze; Rachael S. Watso 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

## Abstract ## Background The adeno‐associated virus (AAV) has many safety features that favor its use in the treatment of arthritic conditions; however, the conventional, single‐stranded vector is inefficient for gene delivery to fibroblastic cells that primarily populate articular tissues. This

Global diffuse distribution in the brain

Global diffuse distribution in the brain and efficient gene delivery to the dorsal root ganglia by intrathecal injection of adeno-associated viral vector serotype 1

✍ Naotaka Iwamoto; Atsushi Watanabe; Motoko Yamamoto; Noriko Miyake; Toshiyuki Kur 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB

## Abstract ## Background The success of gene therapy for inherited neurodegenerative diseases such as metachromatic leukodystrophy (MLD) depends on the development of efficient gene delivery throughout the brain guarded by the blood–brain barrier and achieves distribution of the deficient enzyme